Trial intelligence / Profile preview

Haptoglobin administration based on free hemoglobin in cardiac surgery and postoperative renal function

jRCT1051250247Recruiting

Start
Apr 2026
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial of haptoglobin in Cardiac valve disease (VHD), aortic aneurysm, aortic dissection and 2 more (2 arms). Started Apr 2026; status: recruiting.

02

Drugs

haptoglobin
03

Conditions

Cardiac valve disease (VHD)aortic aneurysmaortic dissectioncoronary arteriosclerosisacute kidney failure (AKF)

Beyond the preview

Go deeper on jRCT1051250247.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1051250247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call